Related Experiment Video
Updated: Sep 3, 2025

Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
Hypertriglyceridemia in Preterm Infants
Alvin P Chan1, Daniel T Robinson2, Kara L Calkins3
1Department of Pediatrics, Division of Pediatric Gastroenterology, David Geffen School of Medicine UCLA, Los Angeles, CA.
Insights
Preterm infants face hypertriglyceridemia (HTG) risks due to various factors. This review clarifies triglyceride metabolism and offers practical management strategies for neonatal HTG.
Area of Science:
- Neonatalogy
- Biochemistry
- Clinical Nutrition
Background:
- Preterm and critically ill infants are susceptible to hypertriglyceridemia (HTG).
- Risk factors include prematurity, lipid emulsion characteristics, and critical illness.
- Current management lacks a standardized definition and evidence-based approach.
Purpose of the Study:
- To review triglyceride and intravenous lipid emulsion metabolism in neonates.
- To correlate metabolic pathways with HTG risk factors.
- To provide practical management considerations for neonatal HTG.
Main Methods:
- Literature review focusing on neonatal lipid metabolism.
- Analysis of factors contributing to hypertriglyceridemia.
- Synthesis of current evidence for management strategies.
Main Results:
- Detailed overview of triglyceride and intravenous lipid emulsion metabolism.
- Explanation of how prematurity, lipid dose/composition, and critical illness impact HTG.
- Identification of gaps in current clinical practice.
Conclusions:
- Understanding lipid metabolism is crucial for neonatal care.
- Standardized definitions and evidence-based guidelines are needed for HTG management.
- Practical strategies can aid clinicians in managing neonatal hypertriglyceridemia.
Abstract:
Preterm and critically ill infants are at risk for hypertriglyceridemia (HTG). Common risk factors for HTG include prematurity, intravenous lipid emulsion dose and oil composition, reduced lipoprotein lipase activity, fetal growth restriction, sepsis, and renal failure. Despite these risk factors, clinicians lack a universally agreed upon definition for HTG and evidence-based approach to HTG management. This review provides a detailed overview of triglyceride and intravenous lipid emulsion metabolism and how this relates to specific HTG risk factors, along with some practical considerations for managing HTG in the neonatal population.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...

